Regulatory reference: | According to OECD 456. |
Claim: | No endocrin disruption |
Application field: | Raw ingredients and finished products. |
Description of the test: | The purpose of the test is identifying substances that interfere with 17-ß estradiol and testosterone production. |
Regulatory reference: | Proprietary method |
Claim: | Mucoadhesive effect |
Application field: | Finished products for direct application on external mucosae. |
Description of the test: | Gravimetric analysis of the adhesion of a product on a layer of mucin against the same product on an untreated plane. Detachment kinetics in terms of percentage of adhesion against a non-adhesive control. |
Regulatory reference: | Proprietary method |
Claim: | Mucoadhesive effect |
Application field: | Finished products for direct application on external mucosae. |
Description of the test: | Analysis of the resistance to washing off with and without a basal layer of mucin. Determination of the percentage of resistance against the same product on substrate without mucin. |
Regulatory reference: | UE Regulation |
Claim: | Titer of substances |
Application field: | Cosmetics and medical devices. |
Description of the test: | Analysis of trace substances, residues and impurities for quality control purposes through UPLC or GC-MS. Includes sample preparation. |
Regulatory reference: | Regulation 1223/209 |
Claim: | Titer of substances and Limit of preservatives |
Application field: | Preservatives, dyes, sunscreen filters. |
Description of the test: | Quantification method for the measurement of the titer of substances by HPLC, UPLC, GC-MS after preparative steps. |
Regulatory reference: | OECD 471 |
Claim: | Non mutagenic |
Application field: | Raw ingredients for medical devices or cosmetics. |
Description of the test: | Analysis of genotoxicity of a substance according to OECD 471. |